These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25537674)

  • 1. Change of Fecal Flora and Effectiveness of the Short-term VSL#3 Probiotic Treatment in Patients With Functional Constipation.
    Kim SE; Choi SC; Park KS; Park MI; Shin JE; Lee TH; Jung KW; Koo HS; Myung SJ;
    J Neurogastroenterol Motil; 2015 Jan; 21(1):111-20. PubMed ID: 25537674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotics Ameliorate Stool Consistency in Patients with Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Study.
    Yoon JY; Cha JM; Oh JK; Tan PL; Kim SH; Kwak MS; Jeon JW; Shin HP
    Dig Dis Sci; 2018 Oct; 63(10):2754-2764. PubMed ID: 29876777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotic VSL#3 Treatment Reduces Colonic Permeability and Abdominal Pain Symptoms in Patients With Irritable Bowel Syndrome.
    Boonma P; Shapiro JM; Hollister EB; Badu S; Wu Q; Weidler EM; Abraham BP; Devaraj S; Luna RA; Versalovic J; Heitkemper MM; Savidge TC; Shulman RJ
    Front Pain Res (Lausanne); 2021; 2():691689. PubMed ID: 35295488
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome.
    Kim HJ; Camilleri M; McKinzie S; Lempke MB; Burton DD; Thomforde GM; Zinsmeister AR
    Aliment Pharmacol Ther; 2003 Apr; 17(7):895-904. PubMed ID: 12656692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Probiotics in Children With Functional Abdominal Pain Disorders and Functional Constipation: A Systematic Review.
    Wegh CAM; Benninga MA; Tabbers MM
    J Clin Gastroenterol; 2018; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S10-S26. PubMed ID: 29782469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotic administration alters the gut flora and attenuates colitis in mice administered dextran sodium sulfate.
    Nanda Kumar NS; Balamurugan R; Jayakanthan K; Pulimood A; Pugazhendhi S; Ramakrishna BS
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1834-9. PubMed ID: 19120873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating.
    Kim HJ; Vazquez Roque MI; Camilleri M; Stephens D; Burton DD; Baxter K; Thomforde G; Zinsmeister AR
    Neurogastroenterol Motil; 2005 Oct; 17(5):687-96. PubMed ID: 16185307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial.
    Airaksinen K; Yeung N; Lyra A; Lahtinen SJ; Huttunen T; Shanahan F; Ouwehand AC
    Benef Microbes; 2019 Jul; 10(6):617-627. PubMed ID: 31131616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of administering a multi-species probiotic mixture on the changes in fecal microbiota and symptoms of irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Yoon H; Park YS; Lee DH; Seo JG; Shin CM; Kim N
    J Clin Biochem Nutr; 2015 Sep; 57(2):129-34. PubMed ID: 26388670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a probiotic formula on gastrointestinal health, immune responses and metabolic health in adults with functional constipation or functional diarrhea.
    Zheng Y; Xu L; Zhang S; Liu Y; Ni J; Xiao G
    Front Nutr; 2023; 10():1196625. PubMed ID: 37497057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of a probiotics mixture in the treatment of childhood constipation: a pilot study.
    Bekkali NL; Bongers ME; Van den Berg MM; Liem O; Benninga MA
    Nutr J; 2007 Aug; 6():17. PubMed ID: 17683583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease.
    Fedorak RN; Feagan BG; Hotte N; Leddin D; Dieleman LA; Petrunia DM; Enns R; Bitton A; Chiba N; Paré P; Rostom A; Marshall J; Depew W; Bernstein CN; Panaccione R; Aumais G; Steinhart AH; Cockeram A; Bailey RJ; Gionchetti P; Wong C; Madsen K
    Clin Gastroenterol Hepatol; 2015 May; 13(5):928-35.e2. PubMed ID: 25460016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea.
    Brigidi P; Vitali B; Swennen E; Bazzocchi G; Matteuzzi D
    Res Microbiol; 2001 Oct; 152(8):735-41. PubMed ID: 11686387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An efficacy and safety study of bifidobacterium tetragenous viable bacteria tablets in the treatment of constipation in patients with type 2 diabetes mellitus].
    Yuan T; Zhao WG; Cao Y; Li Q; Yao MX; Hao XX; Yu H; Jiang CE; Wang HF; Wang SP; Wei XB; Qiu W
    Zhonghua Nei Ke Za Zhi; 2018 Apr; 57(4):252-257. PubMed ID: 29614582
    [No Abstract]   [Full Text] [Related]  

  • 16. Bifidobacterium longum and VSL#3
    Chen X; Fu Y; Wang L; Qian W; Zheng F; Hou X
    Dev Comp Immunol; 2019 Mar; 92():77-86. PubMed ID: 30227219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INFLUENCE OF DRINKING A PROBIOTIC FERMENTED MILK BEVERAGE CONTAINING BIFIDOBACTERIUM ANIMALIS ON THE SYMPTOMS OF CONSTIPATION.
    Moreira TR; Leonhardt D; Conde SR
    Arq Gastroenterol; 2017; 54(3):206-210. PubMed ID: 28591244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised clinical trial: efficacy of Lactobacillus paracasei-enriched artichokes in the treatment of patients with functional constipation--a double-blind, controlled, crossover study.
    Riezzo G; Orlando A; D'Attoma B; Guerra V; Valerio F; Lavermicocca P; De Candia S; Russo F
    Aliment Pharmacol Ther; 2012 Feb; 35(4):441-50. PubMed ID: 22225544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is-it possible to distinguish irritable bowel syndrome with constipation from functional constipation?
    Bouchoucha M; Devroede G; Bon C; Bejou B; Mary F; Benamouzig R
    Tech Coloproctol; 2017 Feb; 21(2):125-132. PubMed ID: 28066860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice.
    Wang CS; Li WB; Wang HY; Ma YM; Zhao XH; Yang H; Qian JM; Li JN
    World J Gastroenterol; 2018 Oct; 24(37):4254-4262. PubMed ID: 30310258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.